Updated on 6 August 2015
Singapore: As per reports, British drug giant, GlaxoSmithKline has planned to invest nearly Rs 1,000 crore in setting up a manufacturing facility in Karnataka, India. The pharma major has been allotted 50 acres by the Karnataka Industrial Area Development Board (KIADB) to set up the unit.
The investment proposal was made during a recent meeting of Mr Ian Felton, deputy high commissioner, British High Commission, Bengaluru, and Mr Richard Heald, CEO, UK India Business Council, with Mr K Ratna Prabha, state additional chief secretary, Commerce and Industries Department and Mr B S Shekarappa, KIADB CEO.
Established in 1924, GSK is one of the oldest pharmaceutical companies. GSK has two manufacturing units in India, at Nashik and Thane, as well as a clinical development centre in Bengaluru.
According to a statement issued by Mr K Ratna Prabha, additional chief secretary to the government of Karnataka, the company will generate 232 jobs at this facility. This will be GSK's first facility coming up in the last 15 years anywhere in the world, the statement added.